Published in Pharmacoepidemiol Drug Saf on September 01, 2010
Comparative epidemiology of hospital-acquired adverse drug reactions in adults and children and their impact on cost and hospital stay--a systematic review. Eur J Clin Pharmacol (2013) 0.97
Retrospective evaluation of adverse drug reactions induced by antihypertensive treatment. J Pharmacol Pharmacother (2013) 0.85
Monitoring of adverse drug reactions associated with antihypertensive medicines at a university teaching hospital in New Delhi. Daru (2012) 0.85
Pattern of Adverse Drug Reactions Reported with Cardiovascular Drugs in a Tertiary Care Teaching Hospital. J Clin Diagn Res (2015) 0.79
Which adverse events are related to health care during hospitalization in elderly inpatients? Int J Med Sci (2013) 0.78
Patterns, predictors and preventability of adverse drug reactions in the coronary care unit of a tertiary care hospital. Eur J Clin Pharmacol (2011) 0.77
Age- and gender-related differences in drug utilisation and adverse drug reaction patterns among patients in a coronary care unit. Singapore Med J (2014) 0.75
The association of opium with coronary artery disease. Eur J Cardiovasc Prev Rehabil (2007) 1.75
Iranian pharmacists' knowledge, attitude and practice regarding counterfeit drugs. Iran J Pharm Res (2012) 1.56
Serum vitamin D concentration status and its correlation with early biomarkers of remodeling following acute myocardial infarction. Clin Res Cardiol (2011) 1.52
Success rate, procedural complications and clinical outcomes of coronary interventions in octogenarians: a case-control study. J Tehran Heart Cent (2011) 1.47
The impact of cytochrome P450 2C19 polymorphism on the occurrence of one-year in-stent restenosis in patients who underwent percutaneous coronary intervention: A case-match study. Anatol J Cardiol (2015) 1.42
Effects of pioglitazone on blood glucose and inflammatory markers of diabetic kidney transplant patients: a randomized controlled trial. Iran J Kidney Dis (2014) 1.40
Evaluation and monitoring of isotretinoin use in Iran. Arch Iran Med (2012) 1.39
Effects of N-acetylcysteine on the cardiac remodeling biomarkers and major adverse events following acute myocardial infarction: a randomized clinical trial. Am J Cardiovasc Drugs (2014) 1.37
Opium consumption in men and diabetes mellitus in women are the most important risk factors of premature coronary artery disease in Iran. Int J Cardiol (2009) 1.21
Stent-graft exclusion of multiple symptomatic coronary artery fistulae. Tex Heart Inst J (2007) 1.18
Short-term consumption of oral omega-3 and dry eye syndrome. Ophthalmology (2013) 1.12
Sodium bicarbonate plus isotonic saline versus saline for prevention of contrast-induced nephropathy in patients undergoing coronary angiography: a randomized controlled trial. Am J Kidney Dis (2009) 1.12
Clinical outcomes of drug-eluting stents compared with bare metal stents in our routine clinical practice. Hellenic J Cardiol (2008) 1.05
Developing an adverse drug reaction reporting system at a teaching hospital. Basic Clin Pharmacol Toxicol (2008) 1.05
Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting. Cardiovasc Diabetol (2012) 1.04
Clinical efficacy of continuous infusion of piperacillin compared with intermittent dosing in septic critically ill patients. Int J Antimicrob Agents (2006) 1.02
Homocysteine, vitamin B12 and folate levels in premature coronary artery disease. BMC Cardiovasc Disord (2006) 1.02
Knowledge, attitudes and practice of nurse regarding adverse drug reaction reporting. Iran J Nurs Midwifery Res (2012) 1.01
Correlation between ABO blood groups, major risk factors, and coronary artery disease. Int J Cardiol (2005) 1.01
Types and severity of medication errors in Iran; a review of the current literature. Daru (2013) 0.97
Adverse reactions of anti-tuberculosis drugs in hospitalized patients: incidence, severity and risk factors. Pharmacoepidemiol Drug Saf (2007) 0.94
A comprehensive review of adherence to diabetes and cardiovascular medications in Iran; implications for practice and research. J Diabetes Metab Disord (2013) 0.92
The evaluation of albumin utilization in a teaching university hospital in iran. Iran J Pharm Res (2011) 0.91
A drug utilization evaluation study of amphotericin B in neutropenic patients in a teaching hospital in iran. Iran J Pharm Res (2012) 0.89
Outcomes of primary percutaneous coronary intervention in acute myocardial infarction at Tehran Heart Center. Med Princ Pract (2007) 0.88
Oxidative stress in kidney transplantation: causes, consequences, and potential treatment. Iran J Kidney Dis (2011) 0.88
Asymptomatic bacteriuria in type 2 Iranian diabetic women: a cross sectional study. BMC Womens Health (2006) 0.87
Comparison of outcomes of percutaneous coronary intervention on proximal versus non-proximal left anterior descending coronary artery, proximal left circumflex, and proximal right coronary artery: a cross-sectional study. BMC Cardiovasc Disord (2007) 0.87
The association between coronary arterial dominancy and extent of coronary artery disease in angiography and paraclinical studies. Clin Anat (2008) 0.87
Impact of UGT1A9 Polymorphism on Mycophenolic Acid Pharmacokinetic Parameters in Stable Renal Transplant Patients. Iran J Pharm Res (2013) 0.87
Demographics and Angiographic Findings in Patients under 35 Years of Age with Acute ST Elevation Myocardial Infarction. J Tehran Heart Cent (2011) 0.87
The Incidence of Amikacin Ototoxicity in Multidrug-ResistantTuberculosis Patients. Iran J Pharm Res (2011) 0.85
Antituberculosis Drug-Induced Hepatotoxicity in IranianTuberculosis Patients: Role of Isoniazid Metabolic Polymorphism. Iran J Pharm Res (2011) 0.85
Efficacy of continuing education in improving pharmacists' competencies for providing weight management service: three-arm randomized controlled trial. J Contin Educ Health Prof (2012) 0.84
Protection from procedural myocardial injury by omega-3 polyunsaturated fatty acids (PUFAs): is related with lower levels of creatine kinase-MB (CK-MB) and troponin I? Cardiovasc Ther (2013) 0.83
Decentralization and hospital pharmacy services: the case of Iranian university affilliated hospitals. Iran J Pharm Res (2013) 0.83
Risk factors for major complications due to delay in surgery in staged carotid stenting and coronary bypass graft surgery. EuroIntervention (2007) 0.83
Continuous bladder irrigation prevents hemorrhagic cystitis after allogeneic hematopoietic cell transplantation. Urol Oncol (2007) 0.83
Budget impact analysis of conversion from cyclosporine to sirolimus as immunosuppressive medication in renal transplantation therapy. Clinicoecon Outcomes Res (2013) 0.83
Evaluating the effect of zingiber officinalis on nausea and vomiting in patients receiving Cisplatin based regimens. Iran J Pharm Res (2011) 0.83
Impact of clinical pharmacist-based parenteral nutrition service for bone marrow transplantation patients: a randomized clinical trial. Support Care Cancer (2013) 0.82
Potential of Drug Interactions among Hospitalized Cancer Patients in a Developing Country. Iran J Pharm Res (2013) 0.82
Simvastatin versus triptorelin in prevention of pain recurrences after surgery for endometriosis. Med Sci Monit (2013) 0.81
Factors predicting discontinuation of a hospital-based cardiac rehabilitation programme. Kardiol Pol (2009) 0.81
Percutaneous transvenous mitral commissurotomy: significance of echocardiographic assessment in prediction of immediate result. Arch Iran Med (2012) 0.81
Clinical characteristics and risk assessment of ST-segment elevation myocardial infarction patients of an Iranian referral center. J Cardiovasc Med (Hagerstown) (2012) 0.81
Staged carotid artery stenting and coronary artery bypass surgery versus isolated coronary artery bypass surgery in concomitant coronary and carotid disease. J Invasive Cardiol (2013) 0.80
Applying quantitative methods for detecting new drug safety signals in pharmacovigilance national database. Pharmacoepidemiol Drug Saf (2007) 0.79
A novel scoring system for identifying high-risk patients undergoing carotid stenting. Arch Iran Med (2006) 0.79
In-hospital and mid-term clinical outcomes after percutaneous coronary intervention with the use of sirolimus- or paclitaxel-eluting stents. Kardiol Pol (2009) 0.79
Mid-Term Follow-Up of Drug-Eluting Stenting for In-Stent Restenosis: Bare-Metal Stents versus Drug-Eluting Stents. J Tehran Heart Cent (2013) 0.78
On-label and off-label use of drug-eluting stents: comparison of short- and long-term outcomes. Tex Heart Inst J (2012) 0.78
Selective versus exclusive use of drug-eluting stents in treating multivessel coronary artery disease: a real-world cohort study. Tex Heart Inst J (2014) 0.78
Effectiveness of regular versus glargine insulin in stable critical care patients receiving parenteral nutrition: a randomized controlled trial. Pharmacotherapy (2015) 0.77
Frequency and predictors of renal artery stenosis in patients undergoing simultaneous coronary and renal catheterization. J Tehran Heart Cent (2012) 0.77
Adverse reactions to antibiotics in hospitalized Iranian children. J Microbiol Immunol Infect (2008) 0.77
Adverse drug reactions in a department of pediatric surgery. J Trop Pediatr (2005) 0.76
Effectiveness of Two-Year versus One-Year Use of Dual Antiplatelet Therapy in Reducing the Risk of Very Late Stent Thrombosis after Drug-Eluting Stent Implantation. J Tehran Heart Cent (2012) 0.76
Anti-tuberculosis drugs adverse reactions: a review of the Iranian literature. Expert Opin Drug Saf (2014) 0.76
Serum vitamin D concentration and potential risk factors for its deficiency in HIV positive individuals. Curr HIV Res (2012) 0.76
Evaluating the Effect of Intracoronary N-Acetylcysteine on Platelet Activation Markers After Primary Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction. Am J Ther (2016) 0.76
Three years evaluation of drug shortages from educational pharmacies in tehran. Iran J Pharm Res (2012) 0.75
Doppler tissue imaging: a non-invasive technique for estimation of left ventricular end diastolic pressure in severe mitral regurgitation. J Tehran Heart Cent (2010) 0.75
Organizational performance, Marketing strategy, and Financial strategic alignment: an empirical study on Iranian pharmaceutical firms. Daru (2013) 0.75
Impact of side-branch flow in coronary bifurcation intervention. J Tehran Heart Cent (2012) 0.75
Outcomes of percutaneous coronary intervention on saphenous vein graft and native coronary vessels. J Tehran Heart Cent (2011) 0.75
Biodegradable-Polymer Biolimus-Eluting Stents versus Durable-Polymer Everolimus-Eluting Stents at One-Year Follow-Up: A Registry-Based Cohort Study. Tex Heart Inst J (2016) 0.75
"Precision" or "relevance"? Reporting considerations for articles focusing on evaluation of search strategies. J Clin Epidemiol (2013) 0.75
The Bioavailability of Salbutamol in Urine via Volumatic and Nonvolumatic Valved Holding Chambers. World Allergy Organ J (2011) 0.75
Isoniazid blood levels in patients with pulmonary tuberculosis at a tuberculosis referral center. Chemotherapy (2010) 0.75
A 3-armed randomized controlled trial of nurses' continuing education meetings on adverse drug reactions. J Contin Educ Health Prof (2015) 0.75
Mycophenolic Acid pharmacokinetics early after kidney transplant. Exp Clin Transplant (2012) 0.75
Evaluation of Renal Toxicity of Colistin Therapy With Neutrophil Gelatinase-associated Lipocalin: a Biomarker of Renal Tubular Damage. Iran J Kidney Dis (2017) 0.75
Compounding practices in Iran. Int J Pharm Compd (2014) 0.75
Metabolic syndrome: stronger association with coronary artery disease in young men in comparison with higher prevalence in young women. Coron Artery Dis (2007) 0.75
New high-performance liquid chromatographic method for serum analysis of oxazepam: application to bioequivalence and pharmacokinetic study. Acta Pol Pharm (2008) 0.75
A new universal high-performance liquid chromatographic method for determination of 1,4-benzodiazepines as bulk drugs and in pharmaceutical formulations. Acta Pol Pharm (2008) 0.75
Pattern and associated factors of potential drug-drug interactions in both pre- and early post-hematopoietic stem cell transplantation stages at a referral center in the Middle East. Ann Hematol (2014) 0.75
The effect of capital structure on the profitability of pharmaceutical companies the case of iran. Iran J Pharm Res (2013) 0.75
Serum copper (cu) alterations in pulmonary tuberculosis patients under treatment with ethambutol. Biol Trace Elem Res (2008) 0.75
Comparison of 1-year Major Adverse Cardiac Events in Patients Undergoing Primary Percutaneous Coronary Intervention Receiving Intracoronary Bolus Only Versus Intracoronary Bolus Plus Infusion of Glycoprotein IIb/IIIa Inhibitors. Crit Pathw Cardiol (2016) 0.75
Fatalities following skin exposure to arsenic. Clin Toxicol (Phila) (2007) 0.75
Major adverse events, six months after endovascular revascularization for critical limb ischemia in diabetic patients. Arch Iran Med (2013) 0.75
Calcitriol for Oral Mucositis Prevention in Patients With Fanconi Anemia Undergoing Hematopoietic SCT: A Double-Blind, Randomized, Placebo-Controlled Trial. Am J Ther (2015) 0.75
Optimized determination of lorazepam in human serum by extraction and high-performance liquid chromatographic analysis. Acta Pharm (2006) 0.75
Effect of completion of cardiac rehabilitation on heart rate recovery. Asian Cardiovasc Thorac Ann (2008) 0.75
Impact of Sex on Long-term Clinical Outcomes After Percutaneous Coronary Intervention. Crit Pathw Cardiol (2017) 0.75